We are live on ! Find out more
KL

KCK Ltd Portfolio holdings

AUM $15.1M
1-Year Est. Return 30.14%
This Fund
S&P 500
This Quarter Est. Return
+64.49%
1 Year Est. Return
+30.14%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$67.3M
AUM Growth
+$577K
Cap. Flow
-$674K
Cap. Flow %
-1%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SGHT icon
Sight Sciences
SGHT
+$674K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGHT icon
1
Sight Sciences
SGHT
$386M
$41.2M 61.22%
4,715,562
-60,670
-1% -$674K
NPCE icon
2
Neuropace
NPCE
$474M
$26.1M 38.74%
5,621,111
RNTX
3
Rein Therapeutics
RNTX
$67.4M
$27.7K 0.04%
22,341

Similar funds

KCK Ltd's Q1 2023 Portfolio in Review

As of Q1 2023, KCK Ltd held 3 positions worth $67.3M, up 0.87% from $66.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. KCK Ltd opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • KCK Ltd's biggest Q1 2023 reduction was Sight Sciences, cutting an estimated $674K.
  • KCK Ltd's ten largest holdings make up 100% of its $67.3M portfolio in Q1 2023.
  • KCK Ltd opened 0 new positions and closed 0 in Q1 2023.
  • KCK Ltd's portfolio value rose 0.87% quarter-over-quarter to $67.3M.

Based on KCK Ltd's 13F filing for Q1 2023, filed 5 May 2023.